Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Propofol Medium/Long Chain Fat Emulsion in Healthy Chinese Subjects
NCT07057609Phase 1Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Oct 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of propofol injection (veterinary) in general anesthesia and sedation (2 arms), sponsored by Haisco Pharmaceutical Group Co., Ltd. Primary endpoints: Maximum Observed Plasma Concentration, Area Under the Concentration-Time Curve From Time Zero to Last Quantifiable Concentration and 1 more. Started Oct 2018; status: completed.
02
Drugs
propofol injection (veterinary)
03
Conditions
general anesthesiasedation
Beyond the preview
Go deeper on NCT07057609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07057609.